CryoPort Inc header image

CryoPort Inc

CYRX

Equity

ISIN null / Valor 28284615

NASDAQ (2026-02-25)
USD 8.48+2.54%

CryoPort Inc
UMushroom community rating:

star star star star star
2.50 2 votes No rating yet
NegativeNeutralPositive

About company

CryoPort Inc is a specialized logistics and supply chain solutions provider focused on serving the life sciences industry. Established by a team of doctors, the company has significantly expanded its offerings beyond its initial logistics support to encompass a comprehensive suite of supply chain solutions. These solutions cater to various stages of the life sciences research, development, and manufacturing processes. As a standalone vendor, CryoPort supports the entire temperature-controlled supply chain, ensuring the safe and efficient transport of sensitive biological materials. The company's Integrated BioServices solutions are designed to address the complex needs of advanced therapies, ranging from clinical trials to commercial material management. Additionally, CryoPort's IntegriCell cryopreservation services offer standardized protocols, processes, and equipment, focusing on the provision of consistent, high-quality leukapheresis starting material. This broad range of services positions CryoPort as a key partner for organizations within the life sciences sector, seeking reliable support for their critical supply chain and logistics needs.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

40.2%1Y
-62.2%3Y
-85.8%5Y

Performance

93.6%1Y
80.2%3Y
77.5%5Y

Volatility

Market cap

425 M

Market cap (USD)

Daily traded volume (Shares)

418,793

Daily traded volume (Shares)

1 day high/low

7.98 / 7.48

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

2.50

2 votes
Performance:
starstarstarstarstar
2.50
Innovation:
starstarstarstarstar
2.50
Society:
starstarstarstarstar
2.50
Nature:
starstarstarstarstar
2.50
Tilly Chapman
United Kingdom, 26 Oct 2025
star star star star star
decent performance so far
Mathias Dirksmeier
Switzerland, 25 Mar 2025
star star star star star
No

EQUITIES OF THE SAME SECTOR

Beximco Pharmaceuticals Ltd
Beximco Pharmaceuticals Ltd Beximco Pharmaceuticals Ltd Valor: 2318407
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%GBP 0.42
Viking Therapeutics Inc
Viking Therapeutics Inc Viking Therapeutics Inc Valor: 24839858
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.87%USD 33.12
CureVac N.V.
CureVac N.V. CureVac N.V. Valor: 56537572
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 4.66
Nano-X Imaging Ltd.
Nano-X Imaging Ltd. Nano-X Imaging Ltd. Valor: 56410599
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.82%USD 2.45
ALX Oncology Holdings Inc
ALX Oncology Holdings Inc ALX Oncology Holdings Inc Valor: 55754366
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.22%USD 2.42
ACELYRIN INC
ACELYRIN INC ACELYRIN INC Valor: 126441937
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 2.27
Stride Inc
Stride Inc Stride Inc Valor: 58406765
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.67%USD 84.22
Biohaven Research Ltd
Biohaven Research Ltd Biohaven Research Ltd Valor: 121902526
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.95%USD 11.51
Cooper Companies Inc
Cooper Companies Inc Cooper Companies Inc Valor: 132951296
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.11%USD 83.47
Amneal Pharmaceuticals Inc
Amneal Pharmaceuticals Inc Amneal Pharmaceuticals Inc Valor: 41368351
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.55%USD 14.58